Compared with healthy subjects, obese patients with hepatic steatosis and increased intramuscular triglyceride (IMTG) had significantly lower levels of circulating SIRT4, which was strictly related to some parameters reckoned as CAD risk factors. Here, SIRT4 is linked to coronary artery disorder.